About this trial
The purpose of this study protocol is to assess the effect of concurrent aerobic and resistance training in patients with type 2 diabetes on vitamin D treatment
Eligibility criteria
Qualifiers
Adults (females or males) older than 18 years old with a diagnosis of T2D in the clinic database
Patients who have been taking the combination therapy of metformin + sodium-glucose transport protein 2 inhibitors (iSGLT2), as recommended by the redGDPS 2023, with stable medication for the past 6 months.
Diabetic patients taking prescribed VitD treatment for at least 6 months (intervention group) and diabetic patients not taking prescribed VitD (control group)
Patients who signed the informed consent
Disqualifiers
Patients taking other medication different than metformin + iSGLT2 (including combinations and insulin)
Patients taking polyvitaminic supplementation at the inclusion for at least, 1 month before the intervention
Female subjects who are pregnant
Patients who did not sign the informed consent
Trial design
Treatments tested in this trial
- Resistance training
Treatment groups
Sponsors and collaborators
University Ramon Llull
Lead sponsor
University of Barcelona
Collaborator
Islamic Azad University, Sanandaj
Collaborator
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Collaborator
Institut Català de la Salut
Collaborator